January, 08 2026 Thursday 14:22 Hrs
Last update 11-9-2025
  • SENSEX :   84,368.54

  • Top commodity trading and broking companies in India-592.60( -0.70%) 08-Jan-2026
top-arrow-market
Sensex 84344.51 -616.63  (-0.73) 08-Jan-2026
Previous Day Close
84961.14
Today's High/Low
High Low
  •  
  •  
84965.27 84207.45

Company News Details

Torrent Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
500420
INE685A01028
249.8252811
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TORNTPHARM
64.88
138466.49
EPS(TTM)
Face Value()
Div & Yield %
63.06
5
0.15
 

Torrent Pharmaceuticals Ltd
Torrent Pharma credit rating unchanged as India Ratings reaffirms AA+
Jan 03,2026
Torrent Pharmaceuticals said India Ratings and Research has reaffirmed the credit rating of the company’s existing banking facilities, issuer rating and non-convertible debentures at IND AA+ with a stable outlook.

The rating agency has also assigned a short-term rating of IND A1+ to Torrent Pharma's proposed commercial paper programme, indicating a strong degree of safety with respect to timely servicing of financial obligations.

The company's securities transfer and stakeholders relationship committee will meet on 5 January 2026 to consider the issuance of secured non-convertible debentures through a private placement, within the borrowing limits already approved by the board in July 2025.

Torrent Pharma is the flagship company of the Torrent Group. It is ranked 7th in the Indian Pharmaceuticals Market and is amongst the Top 5 in the therapeutics segments of Cardiovascular (CV), Gastro Intestinal (GI), Central Nervous System (CNS) and Cosmo-Dermatology. It is a specialty-focused company with ~76% of its revenues in India from chronic & sub-chronic therapies. It has presence in 50+ countries and is ranked No. 1 amongst the Indian pharma companies in Brazil and Germany. Torrent has 8 manufacturing facilities, of which 5 are USFDA approved.

On a consolidated basis, the company's net profit rose 30.46% to Rs 591 crore while net sales rose 14.66% to Rs 3246 crore in Q2 September 2025 over Q2 September 2024.

Shares of Torrent Pharmaceuticals rose 0.96% to settle at Rs 3884.85 on Friday, 2 January 2026.

Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.